A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting

A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting

Abstract Background The xanthine oxidase inhibitor allopurinol that is commonly used to treat gout, has been suggested to have pleiotropic effects that are likely to reduce the incidence of myocardial infarction (MI) in at risk individuals. The aim of this meta-analysis was to assess the efficacy of...

Full description

Bibliographic Details
Main Authors: Tejas P. Singh, Tristan Skalina, Daniel Nour, Aarya Murali, Sean Morrison, Joseph V. Moxon, Jonathan Golledge
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Myocardial infarction
Allopurinol
Atherosclerosis
Online Access:http://link.springer.com/article/10.1186/s12872-018-0881-6

Similar Items

Similar Items